tbuckley/cabot-search huggingface dataset:
Prostate Cancer Clinical Practice Guidelines in Oncology
Journal: Journal of the National Comprehensive Cancer Network (2004)

Although the incidence of prostate cancer has been increasing (1.4% annually from 1995 to 1999), the age-adjusted death rates from prostate cancer have begun to decline (-4.3% annually from 1994 to 1999), and researchers expect prostate cancer to account for only 28,900 deaths in 2003. This suggests that unless prostate cancer is becoming biologically less aggressive, increased public awareness with earlier detection and treatment of prostate cancer has begun to make an impact on this prevalent disease. To properly identify and manage patients with prostate cancer or any malignancy, physicians must have an in-depth understanding of the natural history and treatment options. To this end, an NCCN panel of leading experts from the fields of urology, radiation oncology, and medical oncology at member institutions was appointed to develop guidelines for the treatment of prostate cancer. For the most recent version of the guidelines, please visit NCCN.org
Queries and Minor Notes.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SOME THEORETIC CONSIDERATIONS ON THE TREATMENT OF GONORRHEA.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
La Traviata
Authors: Allan C. Barnes
Journal: JAMA (1969)

The physician who attends the opera<i>La Traviata</i>is likely to be disturbed by the practice of medicine shown in the last act. The heroine, Violette Valery, is dying of tuberculosis. In the first place, notes the physician in the audience, she is far too buxom and stout to have terminal pulmonary disease. Dr. Grenvil arrives carrying flowers and proceeds to sit familiarly on her bed. After these lapses in professional behavior, he fails to feel her pulse, or listen to her lungs or even to take her temperature. He assists her in getting out of bed (admittedly it is difficult to hit high C recumbent beneath a feather bolster, but this is no way to treat serious pulmonary tuberculosis). Finally he kisses Violetta on the forehead (questionable ethics and very bad hygiene), then he announces to the maid Annina—in a fine bass which easily reaches the back rows of
Furuncular Myiasis: Alternatives to Bacon Therapy
Authors: Oliver Thelin
Journal: JAMA (1994)

<h3>To the Editor.</h3> —I read with interest the article by Brewer et al<sup>1</sup>about myiasis. It was a common problem when I lived in Zimbabwe, Zaire, and Gabon where it is recommended to let clothes and bed linen dry indoors and to iron them when possible as is mentioned in the article. The well-known treatment to extract the larvae is a thick application of petroleum jelly (Vaseline) in order to cut the air supply and make the larvae migrate out of the skin. This usually occurs within a few minutes, and the transparency of the petroleum jelly allows one to watch the egress and catch the larvae. I understand that any substance can block the air supply but I doubt bacon therapy will be successful or feasible in the Muslim countries throughout Africa and Asia, and I wanted to remind readers of the current therapy in endemic areas.
TYPHOID FEVER AT SALEM, OHIO
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Questions and Answers
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer
Authors: Wohlrab J, Bangemann N, Kleine-Tebbe A, Thill M, K&uuml;mmel S, Grischke EM, Richter R, Seite S, L&uuml;ftner D
Journal: Journal of the American Academy of Dermatology (2016)
Clinical Pathology of Human Near-Drowning
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Formula in: Within-Person Across-Neuropsychological Test Variability and Incident Dementia Prenatal Genome Testing Sparks Debate
Authors: Melissa Wachterman, Dan Kiely, Susan Mitchell, Mitchell Kiely
Journal: JAMA (2008)

ditions contributing to death" (no limit on number).Two research assistants who were unaware of the study aims independently abstracted causes of death verbatim from the death certificates.Conditions were categorized into predefined clinically relevant groups and quantified using proportions.Exact binomial 95% confidence intervals (CIs) were calculated using SAS version 9.1 (SAS Institute, Cary, North Carolina).Results.Of the 323 participants, 165 died during follow-up (TABLE 1).Among all decedents, dementia documentation on their death certificates was none, 37.0% (95% CI, 29.6%-44.8%);listed in part 1 line A, 15.8% (95% CI, 10.6%-22.2%);listed in part 1 lines B-D, 35.2% (95% CI, 27.9%-43.0%);and listed in part 2, 16.4% (95% CI, 11.2%-22.9%)(TABLE 2).Seven participants had dementia listed in parts 1 and 2. Among the 114 decedents with a premortem diagnosis of Alzheimer disease, documentation of dementia anywhere on their death certificates was none, 33.3% (95% CI, 24.8%-42.8%);Alzheimer disease, 27.2% (95% CI, 19.3%-36.8%);"dementia" without further specification, 37.7% (95% CI, 28.8%-47.3%);and vascular dementia, 0.9% (95% CI, 0.2%-4.8%).Comment.In this study, dementia, and specifically Alzheimer disease, was underreported on death certificates, raising concerns about the accuracy of mortality statistics based on these documents.Despite the terminal stage of dementia in our cohort, dementia was not recorded on 37% of death certificates.The absence of Alzheimer disease on threequarters of death certificates of decedents with this premortem diagnosis is a particular problem because among the causes of dementia, NCHS ranks only Alzheimer disease among its leading causes of death.This study is limited in that 94% of the cohort died in nursing homes where dementia is more likely to be reported on death certificates compared with hospitals. 2There may be some inaccuracies in the clinical dementia subtypes obtained from the chart.The findings may not be generalizable outside Boston; however, the study sample and nursing homes are comparable with those in the rest of the United States. 4 An appreciation that patients die from and with dementia is necessary to inform end-of-life decision making.Underestimation of the burden of dementia as a major fatal illness may hamper planning of health services needed for persons dying with this condition.
INTERNATIONAL ABSTRACTS
Journal: JAMA (1982)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Front Cover: Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China
Authors: Yutong He, Di Liang, Lingbin Du, Tiantian Guo, Yanyu Liu, Xibin Sun, Ning Wang, Min Zhang, Kuangrong Wei, Baoen Shan, Wanqing Chen
Journal: Cancer Communications (2020)

The cover image is based on the Original Article Clinical characteristics and survival of 5283 esophageal cancer patients: a multicenter study from eighteen hospitals across six regions in China by Yutong He et al., https://doi.org/10.1002/cac2.12087.
Cat-scratch disease: its natural history
Authors: H. A. Carithers
Journal: JAMA (1969)

Cat-scratch disease is usually mild, often unrecognized and almost certainly caused by a microscopic agent. All of 152 patients with this disease had significant lymphadenopathy, but only 8.5% of these progressed to suppuration. An inoculation site was found in 96.2% of the patients, usually on the upper extremities or head. These percentages vary greatly from those in previous reports. All except two patients had a history of cat contact. Complications in this series include thrombocytopenic purpura, encephalitis, an osteolytic lesion and Paranaud's syndrome (oculoglandular fever). Treatment of the disease should be mainly symptomatic. Aspiration is the treatment of choice for suppurating nodes. Antibiotics are probably valueless in either the prevention or treatment of this disease and its complications.
About Rotten Row.
Journal: JAMA (1894)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Quizartinib Bests Chemo for <i>FLT3</i>-Mutant AML
Journal: Cancer Discovery (2018)

Abstract The FLT3 inhibitor quizartinib provided a survival benefit over chemotherapy in a phase III trial of patients with relapsed or refractory FLT3-mutant acute myeloid leukemia. The drug, along with other FLT3 inhibitors, could become a first-line treatment based on results from ongoing studies.
Commentaire des travaux de S. von Delius et al. pp. 854 et A. Meining et al. pp. 860
Journal: Endoscopy (2007)

See also: Development, standardization, and evaluation of NOTES cholecystectomy using a transsigmoid approach in the porcine model: an acute feasibility studyEndoscopy 2007; 39(10): 860-864DOI: 10.1055/s-2007-966904 See also: Effect of pneumoperitoneum on hemodynamics and inspiratory pressures during natural orifice transluminal endoscopic surgery (NOTES): An experimental, controlled study in an acute porcine modelEndoscopy 2007; 39(10): 854-861DOI: 10.1055/s-2007-966920
BOOK REVIEWS
Authors: C. GRIFFEN
Journal: JNCI Journal of the National Cancer Institute (1992)

Journal Article BOOK REVIEWS Get access Catalog of Chromosome Aberrations in Cancer, 4th Edition Felix Mitelman , New York : Wiley-Liss , 1991 . 1987 pp., illus. $250. CONSTANCE GRIFFEN CONSTANCE GRIFFEN The Johns Hopkins Oncology Center Rm.1–120 600 N. Wolfe St. Baltimore, MD 21205 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 84, Issue 3, 5 February 1992, Pages 197–198, https://doi.org/10.1093/jnci/84.3.197-a Published: 05 February 1992
LETTER FROM NEW YORK.
Authors: None P. B. P.
Journal: JAMA (1890)

(FROM OUR OWN CORRESPONDENT.) Commencement Exercises of the College of Physicians and Surgeons—Columbia College—New York County Medical Association—Fifth District Branch of the New York State Medical Association —Annual Outing of the Jenkins Medical Society —The Syms Bequest to the Roosevelt Hospital— Miscellaneous Gleanings. This year the Commencement of the College of Physicians and Surgeons, which, it will be remembered, is the Medical Department of Columbia College, was held for the first time in connection with the various other departments of this University; Mr. Seth Low, the new President of Columbia, having determined to inaugurate this new departure. The Commencement exercises were held at the Metropolitan Opera House, in the presence of a large and brilliant audience, and a large number of degrees were conferred upon the graduates of the various schools. The Law School, which is one of the largest and best in the country, was not represented on this
The generic inequivalence of drugs
Authors: A. B. Varley
Journal: JAMA (1968)

Generic equivalence of drugs is a semantically muddled concept. To be meaningful, the criteria for equivalence must be stated. In this simple study, two different formulations of tolbutamide, both generically equivalent in terms of chemical content and specifications of the<i>United States Pharmacopoeia</i>, were found to be clearly not equivalent as measured by availability of drug to the patient (serum drug levels) or therapeutic efficacy (hypoglycemic response). Clarity in pronouncements on this subject should be established so that confusion in terminology and meaning does not lead to "generic inequivalence" of therapeutic response.
Ultrasound
Authors: Jack Coulehan
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatology associates course
Journal: Hepatology (2003)

Objective: The sedative effects of cetirizine (10 mg once daily), diphenhydramine (50 mg three times daily), and placebo, each administered during a 3-day period, were compared with objective measures of sleepiness and performance.Methods: Twelve atopic subjects received each of the three treatments for 3 consecutive days in a double-blind Latin square design. Subjects received either cetirizine at 8:00am and placebo at 3:00pm and 10:00pm; diphenhydramine at 8:00am, 3:00pm, and 10:00pm; or placebo at all three times. Sleepiness was measured on days 1 and 3 with the multiple sleep latency test at 9:00am, 11:00am, 1:00pm, 3:00pm, and 5:00pm. Performance was assessed with a 60-minute simulated assembly line task at 9:30am, 11:30am, 1:30pm, and 3:30pm. Nightly sleep duration was estimated with actigraphy.Results: Compared with placebo and cetirizine, diphenhydramine produced marked impairment only on the first day of drug administration. The multiple sleep latency test and the simulated assembly line task values remained stable across days with cetirizine and placebo but improved with diphenhydramine, resulting in no differences among the three conditions on the third day.Conclusion: Unlike cetirizine, diphenhydramine produced acute impairment of alertness and performance. By the third day of administration, however, this impairment was no longer present, apparently because of development of tolerance to the sedative effects.
Diseases of the Eye.
Journal: JAMA (1910)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal